Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

Blog

  • Home
  •  
  • Blog



  • Most Read
  • Latest Comments
  • Blog
    • News

    RBA and ASIC up the ante on blockchain project, ASX writes off millions
    Public
  • Blog
    • Satire

    Australia to close borders to Omicron Persei 8
    Public
  • Blog
    • Opinion

    The New Criterion: will the listed sanitiser stocks clean up – or clean out – investors?
    Public
  • Blog
    • Opinion

    Is this the most hated company on the ASX?
    Public
  • Blog
    Opening a new frontier in treating Parkinson’s disease
    • Review
    • November 11, 2022
  • Tremors from the FTX collapse continue to be felt as DigitalX sells off 15% Bitcoin holdings
    • Review
    • January 10, 2023
  • AUDC stablecoin gathers momentum as Novatti confirms integration with XRP Ledger
    • Review
    • June 9, 2022
  • PharmAust completes dosing first cohort for MND treatment, patients respond positively
    • Review
    • January 6, 2023
  • Is this the most hated company on the ASX?
    • Review
    • August 16, 2019

Latest Articles

  • AML3D announces stronger FY26, with positive EBITDA reported in the second half
    AML3D announces stronger FY26, with positive EBITDA reported in the second half
    • News

  • Refurbished tech gives Harris Technology a second life
    Refurbished tech gives Harris Technology a second life
    • News

  • Imagion Biosystems Advances MagSense® Phase 2 Trial
    Imagion Biosystems Advances MagSense® Phase 2 Trial
    • News

  • Acrux-developed Menopause Hormone Therapy to enter Australian market
    Acrux-developed Menopause Hormone Therapy to enter Australian market
    • News

  • Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    • News

  • Rewardle enters medtech space, continues portfolio growth with equity-for-fees
    • News

    Rewardle enters medtech space, continues portfolio growth with equity-for-fees

    Marketing tech company Rewardle (ASX: RXH) is quickly building up a unique portfolio of small businesses where the company is backing themselves to lift their customers’ business so much that they have again secured equity options in lieu of their service fees. This time, it’s with medtech company Cardiac Rhythm Diagnostics.  Both Rewardle and Cardiac

    Read More
    Public
  • Tabcorp demerger: Lottery industry set for shake up as Jumbo founder sells down
    • News

    Tabcorp demerger: Lottery industry set for shake up as Jumbo founder sells down

    In August 2021, Tabcorp (ASX: TAH) and Jumbo Interactive (ASX: JIN) formalised a long-term extension of their reseller agreement which would enable Jumbo to continue selling lottery tickets online through their OzLotteries platform. Following on from that, Jumbo reported almost 200k new active customers which took their total to 836k with business appearing to be

    Read More
    Public
  • Reckon introduces digital payments gateway for businesses to easily accept online payments
    • News

    Reckon introduces digital payments gateway for businesses to easily accept online payments

    Small business owners will soon have another mundane bookkeeping task automated thanks to accounting software company Reckon (ASX: RKN) which has introduced a digital payments gateway to their accounting platform making it effortless for business owners to accept digital payments.  The new service is designed for small business customers that use Reckon’s low-cost accounting software

    Read More
    Public
  • Italian motorcycle pioneer joins Vmoto team with equity stake to push EV movement
    • News

    Italian motorcycle pioneer joins Vmoto team with equity stake to push EV movement

    Often lost in the discourse around electric vehicles is the huge opportunity for motorcycles in the market where manufacturer Vmoto (ASX: VMT) has secured two industry-leading pioneers for the team in Giovanni Castiglioni and Graziano Milone, who will both take equity positions in Vmoto. Castiglioni is best known as the owner of various motorcycle companies

    Read More
    Public
  • Rhythm Biosciences’ new clinical trial shows increases accuracy for their simple cancer blood test
    • News

    Rhythm Biosciences’ new clinical trial shows increases accuracy for their simple cancer blood test

    Colorectal cancer is the second leading cause of cancer-related death in Australia. This can be attributed to the silent nature of the disease, not causing symptoms until tumours are well established.  The Australian Government is all too aware of this, having created the National Bowel Cancer Screening Program with the goal of early detection to

    Read More
    Public
  • Inflation and interest rates: We are not the US
    • Opinion

    Inflation and interest rates: We are not the US

    By reading any of the mainstream financial press across the past twelve months you would have undoubtedly heard that interest rate rises were important, nay, essential, for lowering persistently high inflation.  Afterall, consumer prices have been rising rapidly, and as conventional wisdom suggests, the way to reign in prices is through lifting interest rates. However,Read More
    Public
  • «
  • ‹
  • 392
  • 393
  • 394
  • 395
  • 396
  • ›
  • »

Login or register for free to access unlimited reading

Register Now!
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.